Adlai Nortye (ANL) Equity Ratio (2022 - 2025)
Adlai Nortye (ANL) reported Equity Ratio of 0.24 for Q4 2025, down 167.59% year-over-year from 0.36 in Q4 2024, and down 167.59% on a QoQ basis from 0.36 in Q4 2024.
Adlai Nortye (ANL) has 4 years of Equity Ratio data on file, last reported at 0.24 in Q4 2025.
- Quarterly Equity Ratio fell 167.59% year-over-year to 0.24 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.24 (down 167.59% YoY) and the FY2025 annual result came in at 0.24, down 167.59% from the prior year.
- Equity Ratio slipped to 0.24 in Q4 2025 per ANL's latest filing, from 0.36 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.58 in Q4 2023 and bottomed at 3.32 in Q4 2022.
- The 4-year median for Equity Ratio is 0.36 (2024), against an average of 0.43.
- The widest annual swing landed in 2023, when Equity Ratio jumped 117.34%; it then slumped 167.59% in 2025.
- Tracing ANL's Equity Ratio over 4 years: stood at 3.32 in 2022, then jumped by 117.34% to 0.58 in 2023, then plunged by 37.97% to 0.36 in 2024, then tumbled by 167.59% to 0.24 in 2025.
- Per Business Quant, the three latest ANL Equity Ratio figures stand at 0.24 (Q4 2025), 0.36 (Q4 2024), and 0.5 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 0.73 |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 0.77 |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 0.21 |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | -0.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.24 |
| Dec 31, 2024 | 0.36 |
| Jun 30, 2024 | 0.50 |
| Dec 31, 2023 | 0.58 |
| Dec 31, 2022 | -3.32 |